E. Thomas-Tsagli

发表

Prognostic relevance of apoptotic cell death in non‐Hodgkin's lymphomas: a multivariate survival analysis including Ki67 and p53 oncoprotein expression

C. Kittas, P. Korkolopoulou, M. Angelopoulou, 1998, Histopathology.

Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.

K. Gatter, P. Korkolopoulou, E. Thomas-Tsagli, 2007, Human pathology.

TGF‐&bgr;RII, BAX, IGFIIR, caspase‐5, hMSH3 and hMSH6 alterations are not associated with microsatellite instability or p53 mutations in invasive urothelial carcinoma of the urinary bladder

P. Korkolopoulou, E. Thomas-Tsagli, E. Patsouris, 2007 .

c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.

G. Voutsinas, P. Korkolopoulou, E. Thomas-Tsagli, 2004, Urology.

Gastrointestinal stromal tumor of the gastric serosa protruding to the greater omentum. Report of a giant tumor with a rare histological pattern.

E. Thomas-Tsagli, D. Filippou, P. Skandalakis, 2008, Annali italiani di chirurgia.

Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival.

P. Korkolopoulou, E. Thomas-Tsagli, A. Lazaris, 2002, European urology.

Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival

P. Korkolopoulou, E. Thomas-Tsagli, P. Christodoulou, 1998, Acta Neuropathologica.

Prognostic Implications of Aberrations in p16/pRb Pathway in Urothelial Bladder Carcinomas: A Multivariate Analysis Including p53 Expression and Proliferation Markers

P. Korkolopoulou, E. Thomas-Tsagli, A. Lazaris, 2001, European Urology.

The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.

P. Korkolopoulou, E. Thomas-Tsagli, M. Hadjiyannakis, 1997, Pathology, research and practice.

Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.

A. Papanikolaou, P. Korkolopoulou, E. Thomas-Tsagli, 1993, The American journal of surgical pathology.

Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters.

P. Korkolopoulou, E. Thomas-Tsagli, K. Pavlakis, 1992, European urology.

MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.

P. Korkolopoulou, E. Thomas-Tsagli, A. Priftis, 1997, British Journal of Cancer.

Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in gliomas

A. Papanikolaou, P. Korkolopoulou, E. Thomas-Tsagli, 1994, Histopathology.

Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival

P. Korkolopoulou, E. Thomas-Tsagli, E. Patsouris, 2006, Molecular and Cellular Biochemistry.

Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival.

P. Korkolopoulou, E. Thomas-Tsagli, E. Patsouris, 2008, Human pathology.

Mononucleotide markers of microsatellite instability in carcinomas of the urinary bladder.

G. Voutsinas, P. Korkolopoulou, E. Thomas-Tsagli, 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.

P. Korkolopoulou, E. Thomas-Tsagli, E. Patsouris, 2005, Human pathology.

Mitosin and DNA Topoisomerase II&agr;: Two Novel Proliferation Markers in the Prognostication of Diffuse Astrocytoma Patient Survival

P. Korkolopoulou, E. Thomas-Tsagli, A. Konstantinidou, 2001, Applied immunohistochemistry & molecular morphology : AIMM.

Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms

P. Korkolopoulou, E. Patsouris, E. Thomas-Tsagli, 2002, Neuropathology and applied neurobiology.

Hypoxia‐inducible factor 1α/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis

P. Korkolopoulou, E. Patsouris, E. Thomas-Tsagli, 2004, Neuropathology and applied neurobiology.

Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer

Nikolaos Kavantzas, P. Korkolopoulou, E. Thomas-Tsagli, 2001, Virchows Archiv.

Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.

P. Korkolopoulou, E. Thomas-Tsagli, A. Konstantinidou, 2000, Human pathology.

Activation of extracellular regulated kinases (ERK1/2) predicts poor prognosis in urothelial bladder carcinoma and is not associated with B‐Raf gene mutations

P. Korkolopoulou, E. Thomas-Tsagli, E. Patsouris, 2009, Pathology.

Assessment of proliferating-cell nuclear antigen immunostaining in soft-tissue tumours: Relationship to histological grade and mitotic activity

A. Papanikolaou, P. Korkolopoulou, A. Tsenga, 2005, Journal of Cancer Research and Clinical Oncology.